Form 4: Mesa Laboratories CFO John Sakys Reports Stock Transactions

John Sakys, CFO of Mesa Laboratories, reports the vesting and disposal of restricted stock units and common stock transactions on September 1, 2024.

Summary

• On September 1, 2024, John Sakys, the CFO of Mesa Laboratories, reported transactions involving the company's stock.
• These transactions included the vesting of 1,037 Restricted Stock Units (RSUs) and the subsequent disposal of 454 common stock shares to cover tax obligations.
• The disposal of shares was executed at a price of $133.69 per share.
• Following these transactions, Mr. Sakys directly owns 12,046 shares of common stock and indirectly owns 100 shares as a custodian.
• He also holds 2,072 RSUs.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company executive, and does not inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates